Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Current Liabilities (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Total Current Liabilities for 5 consecutive years, with $200.2 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Total Current Liabilities fell 21.74% year-over-year to $200.2 million, compared with a TTM value of $200.2 million through Dec 2023, down 21.74%, and an annual FY2023 reading of $200.2 million, down 21.74% over the prior year.
  • Total Current Liabilities was $200.2 million for Q4 2023 at Cresco Labs, down from $255.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $288.4 million in Q4 2021 and bottomed at $150.2 million in Q4 2019.
  • Average Total Current Liabilities over 5 years is $229.5 million, with a median of $252.8 million recorded in 2020.
  • The sharpest move saw Total Current Liabilities skyrocketed 68.37% in 2020, then decreased 21.74% in 2023.
  • Year by year, Total Current Liabilities stood at $150.2 million in 2019, then soared by 68.37% to $252.8 million in 2020, then increased by 14.06% to $288.4 million in 2021, then dropped by 11.28% to $255.9 million in 2022, then decreased by 21.74% to $200.2 million in 2023.
  • Business Quant data shows Total Current Liabilities for CRLBF at $200.2 million in Q4 2023, $255.9 million in Q4 2022, and $288.4 million in Q4 2021.